Target intelligence / Profile preview

DNA polymerase

Molecular classification
Enzyme, DNA polymerase family (including subfamilies A, B, C, D, X, Y, RT)
01

Overview

DNA polymerase is an enzyme essential for the synthesis of DNA molecules from deoxynucleoside triphosphates, playing a central role in DNA replication and repair in all living cells[1][5][6]. Inhibitors of DNA polymerase block DNA strand elongation or incorporation, interfering with DNA replication and cell division; this mechanism underlies the action of several anticancer and antiviral drugs[6]. DNA polymerases exist in multiple families (A, B, C, D, X, Y, RT) with specialized functions, structures likened to a right hand with palm, fingers, and thumb subdomains, and typically require divalent metal ions for catalytic activity[2][5][6][8]. Because inhibition of DNA polymerases halts cell proliferation, these enzymes are important therapeutic targets but also pose a risk for toxicity in normal, rapidly dividing cells[6]. Additional details: - "DNA polymerase-mediated DNA synthesis inhibition" is not a canonical target name; the correct target is the enzyme "DNA polymerase". - Multiple small molecule and nucleoside analog drugs inhibit DNA polymerase directly or via incorporation as chain terminators, which is a key therapeutic principle in oncology and antiviral therapy[6]. - Different classes of DNA polymerase exist, including those primarily involved in replication (e.g., polymerase α, δ, ε in eukaryotes) or repair (e.g., polymerase β, λ, μ)[6][8]. - Significant safety concerns arise from inhibition of host DNA polymerases in non-target tissues, particularly in bone marrow, gastrointestinal tract, and in mitochondrial DNA replication (mitochondrial toxicity)[6].

Other names
PolymeraseDeoxyribonucleic acid polymerase
02

Mechanism of action

Polymerase inhibition, Chain termination, Competitive inhibition of nucleotide incorporation

03

Biological functions

DNA replicationDNA repairCell proliferationCell cycle regulation
04

Disease associations

CancerInfectionInherited genetic disorders
05

Safety considerations

Off-target cytotoxicity (especially in proliferating tissues)MyelosuppressionImmunosuppressionNeurotoxicityMitochondrial toxicity
06

Interacting drugs

Cytarabine

6 more in the full profile.

07

Biomarkers

DNA damage biomarker (γ-H2AX)Incorporation of labeled nucleotidesCellular DNA content (by flow cytometry)

Beyond the preview

Go deeper on DNA polymerase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call